Abiopharma

BioQuest acquired BotMakers, Inc. effective April 30, 2025, a company that offers an AI platform featuring voice calling, text messaging, and chatbots. Currently, all BotMakers products are fully functional and being sold to retail customers. Future updates to BotMakers products will be based on customer feedback and usage data. BotMakers has no plans to enhance its technology for conversational AI or chatbots beyond current programming parameters. BotMakers underlying product technology consists of automated workflows that integrate with any Customer Relationship Management system via webhooks. This summary provides an overview of the Agreements material terms. For a complete understanding of the rights and obligations involved, refer to the full text of the Agreement, which is filed as an exhibit to this Current Report on Form 1-U and is incorporated herein by reference.

Additional info from OTC:
BioQuest acquired BotMakers, Inc. effective April 30, 2025, a company that offers an AI platform featuring voice calling, text messaging, and chatbots. Currently, all BotMakers products are fully functional and being sold to retail customers. Future updates to BotMakers products will be based on customer feedback and usage data. BotMakers has no plans to enhance its technology for conversational AI or chatbots beyond current programming parameters. BotMakers underlying product technology consists of automated workflows that integrate with any Customer Relationship Management system via webhooks. This summary provides an overview of the Agreements material terms. For a complete understanding of the rights and obligations involved, refer to the full text of the Agreement, which is filed as an exhibit to this Current Report on Form 1-U and is incorporated herein by reference.